ABMED · GLOBAL REGULATORY & MARKET ACCESS
Asia-Pacific and Eurasian markets
38 international markets (countries and regional markets) in our service materials; each jurisdiction has its own requirements.
Find your target market
HSA
Singapore
Market access overview
HSA uses risk classes A–D. Class A product-registration exemption is distinct from SHARE product notification and dealer licensing; other devices use the applicable evaluation route.
Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.
MDA
Malaysia
Market access overview
MDA registration, the local authorised representative, establishment licensing and applicable CAB conformity assessment are separate requirements. Determine class A–D and the eligible pathway.
Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.
Thai FDA
Thailand
Market access overview
Confirm the Thai FDA risk class, listing, notification or licensing route, local importer qualification and the applicable ASEAN dossier and Thai-language labelling.
Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.
Ministry of Health · Medical devices
Vietnam
Market access overview
Assess A/B declarations and C/D circulation registration separately under the applicable Vietnamese rules and transition arrangements. Use local classification and Vietnamese information.
Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.
FDA Philippines
Philippines
Market access overview
Confirm the local establishment LTO and the applicable CMDN, CMDR or exemption route for the risk class and implementation stage. Maintain the authorised product scope.
Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.
Kemenkes
Indonesia
Market access overview
Assess class A–D, product grouping, a qualified local entity and the applicable circulation authorisation. Prepare technical evidence and Indonesian-language labelling.
Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.
CDSCO
India
Market access overview
Under the Medical Devices Rules 2017, an authorised Indian agent normally applies on MD-14 for an MD-15 import licence. Assess specific exemptions and class A–D requirements individually.
Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.
DRAP
Pakistan
Market access overview
DRAP distinguishes class A enlistment from class B–D registration. Establishment licensing, manufacturer authorisation and import responsibility must also be assessed.
Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.
Ministry of Health / NDDA
Kazakhstan
Market access overview
Kazakhstan is geographically in Central Asia and is also an EAEU member. Distinguish national registration from the EAEU route, territorial coverage and current transition conditions.
Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.
Ministry of Health / national review authority
Uzbekistan
Market access overview
Confirm Uzbekistan’s applicable national registration procedure, local authorised responsibility, technical evidence and any testing. An EAEU certificate does not automatically replace Uzbek registration.
Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.
Roszdravnadzor
Russia
Market access overview
Distinguish the Russian national and EAEU routes, intended sales territory and current transition arrangements. Assess Russian evidence, testing and applicable QMS inspections.
Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.
Ministry of Health / EAEU authorities
Belarus
Market access overview
Distinguish Belarusian national registration from the EAEU route. Confirm representative responsibility, the certificate territory, evidence and current transition conditions.
Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.
MFDS / designated bodies
South Korea
Market access overview
MFDS uses classes I–IV with notification, certification or approval as applicable. Confirm the importer’s licence, the technical-review route and applicable KGMP evidence individually.
Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.
PMDA / MHLW
Japan
Market access overview
Confirm JMDN, class and the notification, third-party certification or approval route under the PMD Act. Assess the Japanese MAH/D-MAH, foreign-manufacturer registration and QMS responsibilities.
Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.
TFDA
Taiwan
Market access overview
Assess TFDA class I/II/III, the applicable listing or registration route, local medical-device dealer and manufacturing-site QSD requirements. Mainland-origin imports require separate trade-scope checks.
Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.
Department of Health · MDD
Hong Kong
Market access overview
Confirm the applicable MDACS voluntary listing route and Hong Kong Local Responsible Person. Do not present proposed statutory regulation as if all devices already require mandatory registration.
Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.
Medsafe
New Zealand
Market access overview
WAND is a notification database, not a product approval. Assess device scope and exemptions, the actual New Zealand Sponsor and the applicable notification and maintenance duties.
Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.
TGA
Australia
Market access overview
Assess device or IVD classification, exemptions and the applicable ARTG inclusion route. Australian Sponsor responsibility, manufacturer conformity evidence and application audit are separate matters.
Confirm product classification and grouping, qualified local responsibility, technical and quality evidence, labelling, and the applicable application and post-market steps.
Based on the regulatory section of ABMED’s 38-market report, with source material dated 17 November 2026. Confirm current rules and the specific product before implementation. Market coverage does not imply a company office in every market.